Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0003888
UniProt IDQ96L58
Primary gene name(s)B3GALT6
Synonym gene name(s)unknown
Protein nameBeta-1,3-galactosyltransferase 6
Protein functionBeta-1,3-galactosyltransferase that transfers galactose from UDP-galactose to substrates with a terminal beta-linked galactose residue. Has a preference for galactose-beta-1,4-xylose that is found in the linker region of glycosaminoglycans, such as heparan sulfate and chondroitin sulfate. Has no activity towards substrates with terminal glucosamine or galactosamine residues. {ECO:0000269|PubMed:11551958}.
Subcellular locationGolgi apparatus, Golgi stack membrane {ECO:0000269|PubMed:11551958};
Single-pass type II membrane protein {ECO:0000269|PubMed:11551958}.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: Q96L58
Gene Ontology
(Biological Process)
Complete annatation
chondroitin sulfate biosynthetic process [GO:0030206];
glycosaminoglycan biosynthetic process [GO:0006024];
glycosaminoglycan metabolic process [GO:0030203];
heparan sulfate proteoglycan biosynthetic process [GO:0015012];
protein glycosylation [GO:0006486]
Gene Ontology
(Molecular Function)
Complete annatation
galactosylxylosylprotein 3-beta-galactosyltransferase activity [GO:0047220];
UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499];
UDP-galactosyltransferase activity [GO:0035250]
Gene Ontology
(Cellular Component)
Complete annatation
Golgi cisterna membrane [GO:0032580];
Golgi medial cisterna [GO:0005797];
Golgi membrane [GO:0000139];
integral component of membrane [GO:0016021];
membrane [GO:0016020]
Protein-protein interaction126016
Phylogenetic treeQ96L58
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
Brass et al., Science, 2008
Smith et al., J. Immunol, 2010
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model

DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD30.8871784749271980.007450354570815330.0203059211738388
AZA vs. DISU-0.4336998820598650.08966091366081530.620260951134984
AZA vs. IL70.09198107966949080.636449453096990.999311006273513
AZA vs. SAHA-0.8475883747980540.0007100464503517760.0164160125653415
DISU vs. CD3-1.332732675444090.0003076954605375490.00150200821636756
DISU vs. IL70.5158087306610320.04264622880344660.27378372450084
DISU vs. SAHA-0.4120032666812790.1673951441597010.528265486061943
DMSO vs. AZA-0.09475002873735420.5786977530019711
DMSO vs. CD3-0.9925041408052920.002231599580103550.00685683207714868
DMSO vs. DISU0.3371541720726790.1713251063292830.683214964906668
DMSO vs. IL70.1941717247316930.2866551321536720.774847788634857
DMSO vs. SAHA-0.7585873385056650.00167318383819060.0258721058736955
HIV vs. Mock in Activation-0.05574436814459310.9291720241732160.999983755607037
HIV vs. Mock in Latency-0.1911919027815510.2574758292354780.999834320637052
IL7 vs. CD3-0.7894447465805460.0150810341864140.0417707512480373
SAHA vs. CD3-1.758804739272012.17105775068838e-061.63018636287363e-05
SAHA vs. IL7-0.9424947315456840.0001616738333806160.0028558825251641
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change -1.056803942
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) unknown
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK 0.0499137 0.787326
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
0.753 0.996 1.065 1.026 1.009
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

not found

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

not found

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
hsa00532 Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate - Homo sapiens (human)
hsa00534 Glycosaminoglycan biosynthesis - heparan sulfate / heparin - Homo sapiens (human)
hsa01100 Metabolic pathways - Homo sapiens (human)